articleNew England Journal of MedicineAug 12, 2020BRONZE OA

The Effect of Advances in Lung-Cancer Treatment on Population Mortality

National Cancer Institute · Harvard University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Lung cancer is made up of distinct subtypes, including non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Although overall mortality from lung cancer has been declining in the United States, little is known about mortality trends according to cancer subtype at the population level because death certificates do not record subtype information.

Methods

Using data from Surveillance, Epidemiology, and End Results (SEER) areas, we assessed lung-cancer mortality and linked deaths from lung cancer to incident cases in SEER cancer registries. This allowed us to evaluate population-level mortality trends attributed to specific subtypes (incidence-based mortality). We also evaluated lung-cancer incidence and survival according to cancer subtype, sex, and calendar year. Joinpoint software was used to assess changes in incidence and trends in incidence-based mortality.

Citation impact

1,732
total citations
FWCI
125.31
Percentile
100%
References
38
Citations per year

Authors

9

Topics & keywords

Keywords
  • Medicine
  • Lung cancer
  • Incidence (geometry)
  • Population
  • Epidemiology
  • Cancer
  • Relative survival
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.